Guy Faulkner1, Tony Cohn, Gary Remington. 1. Faculty of Physical Education and Health, University of Toronto, 55 Harbord Street, Toronto, Ontario, Canada M5S 2W6. guy.faulkner@utoronto.ca
Abstract
OBJECTIVE: Increasing physical activity must be one component of lifestyle interventions designed to prevent or treat obesity in schizophrenia and there is now a need to develop low cost, practical and accurate measures of physical activity in this population to identify the prevalence of physical (in)activity and to assess the effectiveness of physical activity interventions. The objective of this study was to provide preliminary validation of the Short-Form International Physical Activity Questionnaire (IPAQ), a measurement tool that could prove useful for both clinicians and researchers in the field. METHOD: Reliability and validity data were collected from a sample of 35 outpatients with a DSM-IV diagnosis of schizophrenia. Test-retest repeatability was assessed within the same week and criterion validity was assessed against an RT3 accelerometer. Spearman's correlation coefficients are reported based on the total reported physical activity (minutes) and estimated energy expenditure. RESULT: We found a correlation coefficient of 0.68 for reliability and 0.37 for criterion validity based on total reported minutes of physical activity. There was a nonsignificant correlation (0.30; p>0.05) between the RT3 data and estimated energy expenditure derived from the IPAQ. CONCLUSION: Although not without limitations, the Short-Form IPAQ, when used with individuals with schizophrenia, exhibits measurement properties that are comparable to those reported in the general population and can be considered as a surveillance tool to assess levels of physical activity.
OBJECTIVE: Increasing physical activity must be one component of lifestyle interventions designed to prevent or treat obesity in schizophrenia and there is now a need to develop low cost, practical and accurate measures of physical activity in this population to identify the prevalence of physical (in)activity and to assess the effectiveness of physical activity interventions. The objective of this study was to provide preliminary validation of the Short-Form International Physical Activity Questionnaire (IPAQ), a measurement tool that could prove useful for both clinicians and researchers in the field. METHOD: Reliability and validity data were collected from a sample of 35 outpatients with a DSM-IV diagnosis of schizophrenia. Test-retest repeatability was assessed within the same week and criterion validity was assessed against an RT3 accelerometer. Spearman's correlation coefficients are reported based on the total reported physical activity (minutes) and estimated energy expenditure. RESULT: We found a correlation coefficient of 0.68 for reliability and 0.37 for criterion validity based on total reported minutes of physical activity. There was a nonsignificant correlation (0.30; p>0.05) between the RT3 data and estimated energy expenditure derived from the IPAQ. CONCLUSION: Although not without limitations, the Short-Form IPAQ, when used with individuals with schizophrenia, exhibits measurement properties that are comparable to those reported in the general population and can be considered as a surveillance tool to assess levels of physical activity.
Authors: Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll Journal: World Psychiatry Date: 2011-06 Impact factor: 49.548
Authors: Joseph C Ratliff; Laura B Palmese; Erin L Reutenauer; Ellen Liskov; Carlos M Grilo; Cenk Tek Journal: Compr Psychiatry Date: 2012-03-16 Impact factor: 3.735
Authors: Kelly A Aschbrenner; Mary F Brunette; Raleigh McElvery; John A Naslund; Emily A Scherer; Sarah I Pratt; Stephen J Bartels Journal: J Nerv Ment Dis Date: 2015-06 Impact factor: 2.254
Authors: Stephen J Bartels; Sarah I Pratt; Kelly A Aschbrenner; Laura K Barre; John A Naslund; Rosemarie Wolfe; Haiyi Xie; Gregory J McHugo; Daniel E Jimenez; Ken Jue; James Feldman; Bruce L Bird Journal: Am J Psychiatry Date: 2014-12-12 Impact factor: 18.112
Authors: John A Naslund; Kelly A Aschbrenner; Emily A Scherer; Sarah I Pratt; Stephen J Bartels Journal: Psychiatr Serv Date: 2016-11-01 Impact factor: 3.084
Authors: Stephen J Bartels; Sarah I Pratt; Kelly A Aschbrenner; Laura K Barre; Kenneth Jue; Rosemarie S Wolfe; Haiyi Xie; Gregory McHugo; Meghan Santos; Gail E Williams; John A Naslund; Kim T Mueser Journal: Psychiatr Serv Date: 2013-08-01 Impact factor: 3.084
Authors: Amy M Kilbourne; Margretta Bramlet; Michelle M Barbaresso; Kristina M Nord; David E Goodrich; Zongshan Lai; Edward P Post; Daniel Almirall; Lilia Verchinina; Sonia A Duffy; Mark S Bauer Journal: Contemp Clin Trials Date: 2014-07-30 Impact factor: 2.226